Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Kezar Life Sciences stock | 5.68

Own Kezar Life Sciences stock in just a few minutes.


Fact checked

Kezar Life Sciences, Inc is a biotechnology business based in the US. Kezar Life Sciences shares (KZR) are listed on the NASDAQ and all prices are listed in US Dollars. Kezar Life Sciences employs 40 staff and has a market cap (total outstanding shares value) of USD$260.4 million.

How to buy shares in Kezar Life Sciences

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Kezar Life Sciences. Find the stock by name or ticker symbol: KZR. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Kezar Life Sciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$5.68, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Kezar Life Sciences, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Kezar Life Sciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Kezar Life Sciences share price

Use our graph to track the performance of KZR stocks over time.

Kezar Life Sciences shares at a glance

Information last updated 2020-10-19.
Latest market close USD$5.68
52-week range USD$2.18 - USD$6.67
50-day moving average USD$4.9397
200-day moving average USD$4.9409
Wall St. target price USD$14.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.456

Buy Kezar Life Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Kezar Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Kezar Life Sciences price performance over time

Historical closes compared with the close of $5.68 from 2020-11-16

1 week (2020-11-20) 5.68
1 month (2020-10-29) 6.17%
3 months (2020-08-28) 19.58%
6 months (2020-05-29) 19.08%
1 year (2019-11-29) 117.62%
2 years (2018-11-29) -78.61%
3 years (2017-11-26) N/A
5 years (2015-11-26) N/A

Kezar Life Sciences financials

Gross profit TTM USD$0
Return on assets TTM -18.28%
Return on equity TTM -30.24%
Profit margin 0%
Book value $3.455
Market capitalisation USD$260.4 million

TTM: trailing 12 months

Shorting Kezar Life Sciences shares

There are currently 1.5 million Kezar Life Sciences shares held short by investors – that's known as Kezar Life Sciences's "short interest". This figure is 7.9% up from 1.4 million last month.

There are a few different ways that this level of interest in shorting Kezar Life Sciences shares can be evaluated.

Kezar Life Sciences's "short interest ratio" (SIR)

Kezar Life Sciences's "short interest ratio" (SIR) is the quantity of Kezar Life Sciences shares currently shorted divided by the average quantity of Kezar Life Sciences shares traded daily (recently around 234420.37617555). Kezar Life Sciences's SIR currently stands at 6.38. In other words for every 100,000 Kezar Life Sciences shares traded daily on the market, roughly 6380 shares are currently held short.

However Kezar Life Sciences's short interest can also be evaluated against the total number of Kezar Life Sciences shares, or, against the total number of tradable Kezar Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Kezar Life Sciences's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Kezar Life Sciences shares in existence, roughly 30 shares are currently held short) or 0.0389% of the tradable shares (for every 100,000 tradable Kezar Life Sciences shares, roughly 39 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Kezar Life Sciences.

Find out more about how you can short Kezar Life Sciences stock.

Kezar Life Sciences share dividends

We're not expecting Kezar Life Sciences to pay a dividend over the next 12 months.

Kezar Life Sciences share price volatility

Over the last 12 months, Kezar Life Sciences's shares have ranged in value from as little as $2.18 up to $6.67. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kezar Life Sciences's is 0.1258. This would suggest that Kezar Life Sciences's shares are less volatile than average (for this exchange).

Kezar Life Sciences overview

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials across five autoimmune indications, including lupus nephritis, autoimmune hemolytic anemia, immune thrombocytopenia, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-616, a selective immunoproteasome inhibitor for the treatment of various autoimmune disease indications; and KZR-TBD for the treatment of oncology and autoimmunity. The company was founded in 2015 and is headquartered in South San Francisco, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site